Press Releases :: Cardax, Inc. (CDXI)

Cardax, Inc. Announces Reverse Stock Split of Common Stock

Jan 14, 2020

Cardax Reports Q3 2019 Results

Nov 14, 2019

Cardax Announces Interim Results from CHASE Clinical Trial

Sep 23, 2019

Cardax Reports Q2 2019 Results

Aug 14, 2019

Cardax Files Registration Statement for Proposed $15 Million Follow-On Offering

Aug 14, 2019

Cardax Reports Q1 2019 Results

May 17, 2019

Cardax Reports 2018 Results

Mar 28, 2019

Cardax to Present at NobleCon XV

Jan 25, 2019

Cardax and GNC Announce Expanded ZanthoSyn® Sales and Marketing Program

Dec 3, 2018

Cardax Names Former Amarin Head of Development Paresh N. Soni, MD, PhD, to lead Clinical and Regulatory Strategy

Nov 28, 2018

Subscribe to Receive Updates by E-Mail Cardax News Alerts

*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

© 2025 Cardax, Inc. | Disclaimer and Terms of Use | Accessibility Statement